SE410600B - Sett att framstella nya arylaminopyrimidinderivat - Google Patents

Sett att framstella nya arylaminopyrimidinderivat

Info

Publication number
SE410600B
SE410600B SE7411806A SE7411806A SE410600B SE 410600 B SE410600 B SE 410600B SE 7411806 A SE7411806 A SE 7411806A SE 7411806 A SE7411806 A SE 7411806A SE 410600 B SE410600 B SE 410600B
Authority
SE
Sweden
Prior art keywords
arylaminopyrimidine
derivatives
way
produce new
produce
Prior art date
Application number
SE7411806A
Other languages
English (en)
Swedish (sv)
Other versions
SE7411806L (de
Inventor
C Fauran
G Bourgery
G Raynaud
C Gouret
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7333831A external-priority patent/FR2244459A1/fr
Priority claimed from FR7410327A external-priority patent/FR2265386A2/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of SE7411806L publication Critical patent/SE7411806L/xx
Publication of SE410600B publication Critical patent/SE410600B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7411806A 1973-09-20 1974-09-19 Sett att framstella nya arylaminopyrimidinderivat SE410600B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7333831A FR2244459A1 (en) 1973-09-20 1973-09-20 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics
FR7410327A FR2265386A2 (en) 1974-03-26 1974-03-26 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics

Publications (2)

Publication Number Publication Date
SE7411806L SE7411806L (de) 1975-03-21
SE410600B true SE410600B (sv) 1979-10-22

Family

ID=26217948

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7411806A SE410600B (sv) 1973-09-20 1974-09-19 Sett att framstella nya arylaminopyrimidinderivat

Country Status (12)

Country Link
US (1) US3978055A (de)
JP (1) JPS5088079A (de)
CA (1) CA1008074A (de)
CH (1) CH593266A5 (de)
DE (1) DE2444426A1 (de)
ES (1) ES429869A1 (de)
GB (1) GB1430729A (de)
IT (1) IT1062796B (de)
LU (1) LU70791A1 (de)
NL (1) NL7412494A (de)
SE (1) SE410600B (de)
SU (1) SU645569A3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1534593A (en) * 1976-09-03 1978-12-06 Soc D Etudes Prod Chimique N-2,6-dichlorophenyl-2-aminopyrimidine and therapeutic compositions containing it
JPS57203072A (en) * 1981-06-05 1982-12-13 Sankyo Co Ltd 4-anilinopyrimidine derivative, its preparation, antidepressant comprising it as active ingredient
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
US5254555A (en) * 1989-10-30 1993-10-19 Beecham Group P.L.C. Amino pyrimidin-7-yl substituted benzopyrans for treatment of hypertension
US7481790B2 (en) * 2000-12-27 2009-01-27 Advanced Cardiovascular Systems, Inc. Vessel enlargement by arteriogenic factor delivery
US20030055263A1 (en) * 2001-07-11 2003-03-20 Boehringer Ingelheim Pharma Kg Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
DE10133665A1 (de) * 2001-07-11 2003-01-30 Boehringer Ingelheim Pharma Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
EP1603884A4 (de) * 2003-02-28 2008-05-28 Encysive Pharmaceuticals Inc Pyridin, pyrimidin, quinolin, quinazolin und naphthalen-urotensin-ii-rezeptor-antagonisten
US7320989B2 (en) * 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
US8455489B2 (en) 2003-11-10 2013-06-04 Exelixis, Inc. Substituted pyrimidine compositions and methods of use
JP4772690B2 (ja) 2003-12-03 2011-09-14 ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド チューブリン阻害剤
EA035349B1 (ru) * 2012-11-21 2020-05-29 ПиТиСи ТЕРАПЬЮТИКС, ИНК. ЗАМЕЩЕННЫЕ ПИРИМИДИНОВЫЕ ОБРАТНЫЕ ИНГИБИТОРЫ Bmi-1
EA034866B1 (ru) 2013-08-30 2020-03-31 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Замещенные пиримидиновые ингибиторы bmi-1
US10584115B2 (en) 2013-11-21 2020-03-10 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine BMI-1 inhibitors
CN104262263B (zh) * 2014-08-29 2017-01-11 西安交通大学 一种N,6二苯基嘧啶-4-胺类Bcr-Abl抑制剂及其制备方法和应用
CA3131249A1 (en) * 2019-02-28 2020-09-03 Ptc Therapeutics, Inc. 5-fluoro-2-(6fluoro-2-methyl-1h-benzo(d)imidazol-1-yl)-n4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine dor treating a multiple myeloma
EP3947379A4 (de) * 2019-03-27 2022-12-21 PTC Therapeutics, Inc. Kombinationen zur verwendung in einem verfahren zur behandlung von sarkom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321478A (en) * 1963-09-20 1967-05-23 American Cyanamid Co Aminoethoxyphenyl amine, ether, and sulfide derivatives of pyrimidine

Also Published As

Publication number Publication date
US3978055A (en) 1976-08-31
CA1008074A (fr) 1977-04-05
JPS5088079A (de) 1975-07-15
NL7412494A (nl) 1975-03-24
SU645569A3 (ru) 1979-01-30
DE2444426A1 (de) 1975-03-27
IT1062796B (it) 1985-01-31
AU7344174A (en) 1976-03-25
CH593266A5 (de) 1977-11-30
LU70791A1 (de) 1975-06-11
SE7411806L (de) 1975-03-21
ES429869A1 (es) 1976-10-01
GB1430729A (en) 1976-04-07

Similar Documents

Publication Publication Date Title
SE7614680L (sv) Sett att framstella nya bensodiazepinderivat
SE421615B (sv) Sett att framstella nya tiazolderivat
SE7711848L (sv) Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE411349B (sv) Sett att framstella nya penicilliner
SE397830B (sv) Sett att framstella nya bensodioxol-piperazinderivat
SE413598B (sv) Sett att framstella 7-amino-delta?723-cefem-derivat
SE401176B (sv) Sett att framstella nya hypokalcemiskt verksamma dotriakontapeptidamider
SE7511328L (sv) Sett att framstella nya pyridinderivat
SE386164B (sv) Sett att framstella nya 2-alkylamino-dihydropyridiner
SE399255B (sv) Sett att framstella kinazolinonderivat
SE7603277L (sv) Sett att framstella prostansyraderivat
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE7606178L (sv) Sett att framstella nya cefalosporinderivat
SE400078B (sv) Sett att framstella kinazolinonderivat
SE7509209L (sv) Sett att framstella nya kinolinderivat
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE399712B (sv) Sett att framstella pregnansyraderivat
SE408170B (sv) Sett att framstella nya substituerade nitrobensofenonderivat
SE415252B (sv) Sett att framstella nya oxifenylbutazonderivat
SE401184B (sv) Sett att framstella morfolinderivat
SE413022B (sv) Sett att framstella nya propylendiaminderivat
SE7609666L (sv) Sett att framstella nya 5-aminometyltiazolderivat
SE400281B (sv) Sett att framstella kinazolinonderivat
SE7610170L (sv) Sett att framstella nya aminoimidazol-isokinolinderivat